.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Johnson and Johnson
Teva
Covington
Cantor Fitzgerald
UBS
Federal Trade Commission
McKinsey
Boehringer Ingelheim

Generated: February 18, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to United Kingdom Patent: 0008837.7

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
AstrazenecaFASLODEXfulvestrantINJECTABLE;INTRAMUSCULAR021344-001Apr 25, 2002RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
AstrazenecaFASLODEXfulvestrantINJECTABLE;INTRAMUSCULAR021344-001Apr 25, 2002RXYesYes➤ Try a Free Trial➤ Try a Free TrialY
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist